Northern Trust Corp Xeris Biopharma Holdings, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,158,226 shares of XERS stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,158,226

Previous 1,107,169 4.61%

Holding current value

$3.89 Million

Previous $2.49 Million 32.48%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.06 - $2.96 $105,177 - $151,128	51,057 Added 4.61%	1,158,226 $3.3 Million
Q2 2024 Aug 14, 2024	SELL	$1.7 - $2.45 $89,056 - $128,345	-52,386 Reduced 4.52%	1,107,169 $2.49 Million
Q1 2024 May 14, 2024	SELL	$2.04 - $3.22 $11,848 - $18,701	-5,808 Reduced 0.5%	1,159,555 $2.56 Million
Q4 2023 Feb 13, 2024	BUY	$1.47 - $2.36 $29,614 - $47,544	20,146 Added 1.76%	1,165,363 $2.74 Million
Q3 2023 Nov 13, 2023	SELL	$1.8 - $2.69 $15,418 - $23,042	-8,566 Reduced 0.74%	1,145,217 $2.13 Million
Q2 2023 Aug 11, 2023	BUY	$1.82 - $2.98 $80,454 - $131,733	44,206 Added 3.98%	1,153,783 $3.02 Million
Q1 2023 May 15, 2023	BUY	$1.03 - $1.63 $13,601 - $21,524	13,205 Added 1.2%	1,109,577 $1.81 Million
Q4 2022 Feb 13, 2023	BUY	$1.14 - $1.65 $1,993 - $2,885	1,749 Added 0.16%	1,096,372 $1.46 Million
Q3 2022 Nov 14, 2022	SELL	$1.37 - $1.93 $14,126 - $19,900	-10,311 Reduced 0.93%	1,094,623 $1.71 Million
Q2 2022 Aug 12, 2022	BUY	$1.48 - $2.64 $1.33 Million - $2.37 Million	898,486 Added 435.21%	1,104,934 $1.7 Million
Q1 2022 May 13, 2022	BUY	$2.0 - $2.87 $32,852 - $47,142	16,426 Added 8.64%	206,448 $529,000
Q4 2021 Feb 08, 2022	BUY	$1.8 - $2.93 $342,039 - $556,764	190,022 New	190,022 $557,000

Others Institutions Holding XERS

# of Institutions

143

Shares Held

60M

Call Options Held

148K

Put Options Held

45.7K

View Full List

About Xeris Biopharma Holdings, Inc.

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $457M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

More about XERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Xeris Biopharma Holdings, Inc. Transaction History